SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

Cancer Genetics Q1 EPS $(0.56) Up From $(1.06) YoY, Sales $1.40M Down From $1.80M YoY

Cancer Genetics (NASDAQ:CGIX) reported quarterly losses of $(0.56) per share. This is a 47.17 percent increase over losses of $(1.06) per share from the same period last year. The company reported $1.40 million in sales

Benzinga · -
Cancer Genetics (NASDAQ: CGIX) reported quarterly losses of $(0.56) per share. This is a 47.17 percent increase over losses of $(1.06) per share from the same period last year. The company reported $1.40 million in sales this quarter. This is a 22.22 percent decrease over sales of $1.80 million the same period last year.